What’s the Follow-Up Plan After a Clinical Trial? | Transcript | Chronic Myeloid Leukemia (CML) | Patient Power


What’s the Follow-Up Plan After a Clinical Trial?

Typically the drugs continue to be provided for free for as long as the patient continues to benefit. Now, sometimes if the drug ultimately gets FDA approved, then it may be necessary at some time in the future for a patient to switch over from the research drug to the commercial drug, but of course at that time the drug is FDA approved. And if the person has insurance, it will generally be covered by their insurance.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on September 10, 2019